Logo image of ALHEX.PA

HEXAOM (ALHEX.PA) Stock Fundamental Analysis

Europe - EPA:ALHEX - FR0004159473 - Common Stock

32.1 EUR
+0.6 (+1.9%)
Last: 10/2/2025, 7:00:00 PM
Fundamental Rating

4

ALHEX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 34 industry peers in the Household Durables industry. Both the profitability and the financial health of ALHEX get a neutral evaluation. Nothing too spectacular is happening here. ALHEX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALHEX had positive earnings in the past year.
ALHEX had a positive operating cash flow in the past year.
Of the past 5 years ALHEX 4 years were profitable.
Each year in the past 5 years ALHEX had a positive operating cash flow.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.48%, ALHEX is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
ALHEX's Return On Equity of 6.20% is fine compared to the rest of the industry. ALHEX outperforms 64.71% of its industry peers.
With a decent Return On Invested Capital value of 6.12%, ALHEX is doing good in the industry, outperforming 61.76% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALHEX is in line with the industry average of 9.94%.
Industry RankSector Rank
ROA 2.48%
ROE 6.2%
ROIC 6.12%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

ALHEX has a Profit Margin (1.94%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ALHEX has declined.
ALHEX's Operating Margin of 2.79% is in line compared to the rest of the industry. ALHEX outperforms 44.12% of its industry peers.
ALHEX's Operating Margin has declined in the last couple of years.
ALHEX has a Gross Margin of 19.40%. This is amonst the worse of the industry: ALHEX underperforms 85.29% of its industry peers.
ALHEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.79%
PM (TTM) 1.94%
GM 19.4%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

5

2. Health

2.1 Basic Checks

ALHEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ALHEX has about the same amount of shares outstanding.
Compared to 1 year ago, ALHEX has an improved debt to assets ratio.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.52 indicates that ALHEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ALHEX (2.52) is better than 67.65% of its industry peers.
The Debt to FCF ratio of ALHEX is 9.35, which is on the high side as it means it would take ALHEX, 9.35 years of fcf income to pay off all of its debts.
ALHEX has a better Debt to FCF ratio (9.35) than 64.71% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that ALHEX is not too dependend on debt financing.
ALHEX has a Debt to Equity ratio of 0.24. This is in the better half of the industry: ALHEX outperforms 70.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 9.35
Altman-Z 2.52
ROIC/WACC0.88
WACC6.97%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

ALHEX has a Current Ratio of 1.30. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
ALHEX has a Current ratio of 1.30. This is comparable to the rest of the industry: ALHEX outperforms 41.18% of its industry peers.
A Quick Ratio of 1.01 indicates that ALHEX should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.01, ALHEX is doing good in the industry, outperforming 64.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.01
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The earnings per share for ALHEX have decreased strongly by -56.88% in the last year.
The earnings per share for ALHEX have been decreasing by -13.22% on average. This is quite bad
Looking at the last year, ALHEX shows a very negative growth in Revenue. The Revenue has decreased by -28.88% in the last year.
Measured over the past years, ALHEX shows a decrease in Revenue. The Revenue has been decreasing by -9.93% on average per year.
EPS 1Y (TTM)-56.88%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-80.33%
Revenue 1Y (TTM)-28.88%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-34.05%

3.2 Future

The Earnings Per Share is expected to grow by 37.93% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.02% on average over the next years.
EPS Next Y32.2%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

ALHEX is valuated correctly with a Price/Earnings ratio of 15.51.
67.65% of the companies in the same industry are more expensive than ALHEX, based on the Price/Earnings ratio.
ALHEX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 11.50, the valuation of ALHEX can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALHEX is on the same level as its industry peers.
ALHEX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.29.
Industry RankSector Rank
PE 15.51
Fwd PE 11.5
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALHEX is valued cheaper than 94.12% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALHEX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 25.59
EV/EBITDA 3.64
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

ALHEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALHEX's earnings are expected to grow with 37.93% in the coming years.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y37.93%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

ALHEX has a Yearly Dividend Yield of 1.68%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.63, ALHEX has a dividend in line with its industry peers.
ALHEX's Dividend Yield is slightly below the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.68%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

DP0%
EPS Next 2Y37.93%
EPS Next 3YN/A
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

HEXAOM

EPA:ALHEX (10/2/2025, 7:00:00 PM)

32.1

+0.6 (+1.9%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)09-24 2025-09-24
Earnings (Next)11-07 2025-11-07
Inst Owners14.62%
Inst Owner ChangeN/A
Ins Owners2.84%
Ins Owner ChangeN/A
Market Cap222.77M
Analysts86.67
Price Target41.31 (28.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.68%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)9.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.51
Fwd PE 11.5
P/S 0.31
P/FCF 25.59
P/OCF 14.63
P/B 0.98
P/tB 1.64
EV/EBITDA 3.64
EPS(TTM)2.07
EY6.45%
EPS(NY)2.79
Fwd EY8.7%
FCF(TTM)1.25
FCFY3.91%
OCF(TTM)2.19
OCFY6.84%
SpS104.97
BVpS32.84
TBVpS19.59
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 6.2%
ROCE 7.89%
ROIC 6.12%
ROICexc 12.79%
ROICexgc 39.35%
OM 2.79%
PM (TTM) 1.94%
GM 19.4%
FCFM 1.2%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexcg growth 3Y-17.24%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score6
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 9.35
Debt/EBITDA 1.55
Cap/Depr 43.08%
Cap/Sales 0.9%
Interest Coverage 250
Cash Conversion 42.9%
Profit Quality 61.63%
Current Ratio 1.3
Quick Ratio 1.01
Altman-Z 2.52
F-Score6
WACC6.97%
ROIC/WACC0.88
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.88%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-80.33%
EPS Next Y32.2%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.88%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-34.05%
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%
EBIT growth 1Y-41.69%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.7%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-65.3%
OCF growth 3Y-21.91%
OCF growth 5YN/A